A Photosensitizer-Loaded Polydopamine Nanomedicine Agent for Synergistic Photodynamic and Photothermal Therapy
Molecules · 2023
DOI: 10.3390/molecules28155874 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Shufeng Yan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical Plant Exploitation and Utilization Engineering Research Center of Fujian Province, Sanming University, Sanming 365004, China. Hauptthemen laut MEDLINE: Photochemotherapy, Nanoparticles. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation Cultivation Project, Natural Science Foundation of Fujian Province, Guiding Project of Sanming Science and Technology Plan.
Abstract (Originalsprache)
Photodynamic therapy (PDT) and photothermal therapy (PTT) have emerged as promising non-invasive approaches to cancer treatment. However, the development of multifunctional nanomedicines is necessary to enhance these approaches’ effectiveness and safety. In this study, we investigated a polydopamine-based nanoparticle (PDA-ZnPc+ Nps) loaded with the efficient photosensitizer ZnPc(4TAP)12+ (ZnPc+) through in vitro and in vivo experiments to achieve synergistic PDT and PTT. Our results demonstrated that PDA-ZnPc+ Nps exhibited remarkable efficacy due to its ability to generate reactive oxygen species (ROS), induce photothermal effects, and promote apoptosis in cancer cells. Moreover, in both MCF-7 cells and MCF-7 tumor-bearing mice, the combined PDT/PTT treatment with PDA-ZnPc+ Nps led to synergistic effects. Subcellular localization analysis revealed a high accumulation of ZnPc+ in the cytoplasm of cancer cells, resulting in cellular disruption and vacuolation following synergistic PDT/PTT. Furthermore, PDA-ZnPc+ Nps exhibited significant antitumor effects without causing evident systemic damage in vivo, enabling the use of lower doses of photosensitizer and ensuring safer treatment. Our study not only highlights the potential of PDA-ZnPc+ Nps as a dual-functional anticancer agent combining PDA and PTT but also offers a strategy for mitigating the side effects associated with clinical photosensitizers, particularly dark toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Plant Exploitation and Utilization Engineering Research Center of Fujian Province, Sanming University, Sanming 365004, China.
- School of Resource and Chemical Engineering, Sanming University, Sanming 365004, China.
ORCID-Profile: Shufeng Yan
Förderung
- National Natural Science Foundation Cultivation Project
- Natural Science Foundation of Fujian Province
- Guiding Project of Sanming Science and Technology Plan
- the Start-up Foundation for Advanced Talents in Sanming University
- Key Discipline of Biology in Fujian Province
- Start-up Foundation for Advanced Talents in Sanming University
Zitieren
APA
Yan, S., Dong, L., Hu, Z., Zhang, Y., Xu, W., Xing, J., & Zhang, J. (2023). A Photosensitizer-Loaded Polydopamine Nanomedicine Agent for Synergistic Photodynamic and Photothermal Therapy. Molecules. https://doi.org/10.3390/molecules28155874
Vancouver
Yan S, Dong L, Hu Z, Zhang Y, Xu W, Xing J, et al. A Photosensitizer-Loaded Polydopamine Nanomedicine Agent for Synergistic Photodynamic and Photothermal Therapy. Molecules. 2023. doi:10.3390/molecules28155874
BibTeX
@article{Yan2023,
author = {Yan, Shufeng and Dong, Luying and Hu, Ziyun and Zhang, Yucheng and Xu, Wei and Xing, Jianhong and Zhang, Juncheng},
title = {A Photosensitizer-Loaded Polydopamine Nanomedicine Agent for Synergistic Photodynamic and Photothermal Therapy},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28155874}
}
EUVIMED